A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib
Clinical trial NCT02340611 · COMPLETED
Trial details
- NCT number
- NCT02340611
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2018-06-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.